Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages of ...
Merck KGaA's chief executive Belén Garijo will end her time at the helm of the company next April, five years after taking the job, and will be replaced by Kai Beckmann, who is currently CEO of the ...
It’s been a wonderful season for snow-related schadenfreude here in Florida, where even with the plummeting temps and iguanas, we use our shovels for sandcastles and our salt for margaritas. But ...
The investment seeks to provide investors with an opportunity to invest in gold through the shares and be able to take delivery of physical gold in exchange for those shares. The Trust’s secondary ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...
Copyright © 2026 Insider Inc and finanzen.net GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service ...
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results